retatrutide clinical trials safety 𧬠Explained Retatrutide is one of the most promising investigational peptides currently being studied for weight management and metabolic health. Unlike current GLP-1 medications, Retatrutide activates three hormone receptors: ⒠GLP-1 Unapproved weight-loss drug "reta" sold
Description
Connect with us at LinkedIn
This receptor activity helps support satiety signals that can last throughout the day
Clinical trials have shown that gastrointestinal side effects are among the most common, with nausea reported in 15-20% of patients taking semaglutide for diabetes and up to 44% of those on higher doses for weight management
Sequence is a telehealth provider solely focused on GLP-1 prescriptions
